<DOC>
	<DOC>NCT00108914</DOC>
	<brief_summary>The purpose of this study is to determine if the investigational drug is effective and safe in children with perennial allergic rhinitis.</brief_summary>
	<brief_title>Perennial Allergic Rhinitis Study In Pediatric Subjects</brief_title>
	<detailed_description>A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 50mcg and 100mcg for 12 Weeks in Pediatric Subjects Ages 2 to &lt;12 Years with Perennial Allergic Rhinitis (PAR)</detailed_description>
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Perennial</mesh_term>
	<criteria>Inclusion criteria: Diagnosis of perennial allergic rhinitis. Exclusion criteria: Have significant concomitant medical conditions. Use of corticosteroids or other allergy medications during the study. Have abnormal ECG. Have laboratory abnormality. Have abnormal eye exam.</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Perennial allergic rhinitis</keyword>
	<keyword>pediatric</keyword>
</DOC>